Cherry Lu is the Founding and Executive Partner of Redhill Capital. See sector focus and contact routes.
Cherry Lu is the Founding and Executive Partner of Redhill Capital, a venture capital firm she co-founded in early 2018 after serving as a partner at Sequoia China (also known as Hongshan). She leads the firm’s focus on early- and growth-stage investments specifically within medical innovation, targeting medical technology and biotech companies in China. Redhill Capital typically invests in the healthcare and life science sectors across mainland China, introducing new medical technologies, innovative drugs, and novel medical services. While specific check sizes and lead/follow behavior are not publicly detailed, the firm has backed industry pioneers including Breo (688793), Cofoe Medical Technology (301087), and Liangyihui. Lu holds a clinical medicine degree from Tongji Medical College, an MBA from the Chinese University of Hong Kong, and an EMBA in Health Management from Changjiang Business School, reflecting her deep background in medical marketing and project cooperation. Her distinctive point of view centers on leveraging her health industry experience from roles at Johnson & Johnson China and Medtherm instrument to drive medical innovation through
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Hong Kong.
Investors like Cherry Lu · Full investor directory · Investor access · Company funding database